Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3oa3XVH
via IFTTT